Skip to main content
Top
Published in: Journal of Cancer Survivorship 1/2013

01-03-2013

Decline in physical functioning in first 2 years after breast cancer diagnosis predicts 10-year survival in older women

Authors: Mary Sehl, Xiang Lu, Rebecca Silliman, Patricia A. Ganz

Published in: Journal of Cancer Survivorship | Issue 1/2013

Login to get access

Abstract

Purpose

Breast cancer patients often experience a decline in physical functioning following cancer diagnosis. Although most patients recover after treatment, some patients do not. These changes may be magnified in older women with comorbid conditions and could impact survival outcomes.

Methods

We used longitudinal data from a prospective cohort study of women 65+ years of age, recruited shortly after diagnosis of early stage breast cancer, to examine changes in self-reported physical functioning measured with the Physical Function Index (PF-10) of the Medical Outcomes Study Short Form-36. Outcomes were constructed for small (0.2 SD), medium (0.5 SD), and large (0.8 SD) declines in the PF-10 measurement over two intervals: (1) 3 to 15 months following cancer diagnosis, encompassing treatment and early recovery, and (2) 3 to 27 months following cancer diagnosis, in order to detect sustained recovery versus persistent decline. Cox-proportional hazards regression was used to examine association between survival and decline in PF-10 scores.

Results

A large (>0.8 SD) decline in PF-10 scores from 3 to 27 months predicted shorter 10-year survival (hazard ratio = 1.34, 95 % confidence interval 1.1–1.6). Persistent decline at 27 months was associated with less education, higher baseline PF-10, increased comorbidity, and higher body mass index.

Conclusions

Older women with breast cancer who experience a large and persistent decline in PF-10 are at increased mortality risk. Future research should examine the value of clinical assessment of physical function as a marker for mortality and test interventions to prevent decline in physical function to improve post-treatment survival outcomes.

Implications for Cancer Survivors

Many breast cancer survivors experience a decline in physical functioning in the year following their cancer diagnosis. While the majority of patients recover in the year after treatment is completed, individuals who experience a persistent decline in physical functioning without recovery are at risk of functional decline and early mortality. Our results highlight the importance of assessing functional status to identify those at risk for functional decline, and suggest a potential role for early intervention in these individuals.
Literature
1.
go back to reference American Cancer Society: Breast cancer facts and figures 2010. American Cancer Society: Breast cancer facts and figures 2010.
2.
go back to reference Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26:759–67.PubMedCrossRef Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26:759–67.PubMedCrossRef
3.
go back to reference Garman KS, Pieper CF, Seo P, et al. Function in elderly cancer survivors depends on comorbidities. J Gerontol A Biol Sci Med Sci. 2003;M1119–24. Garman KS, Pieper CF, Seo P, et al. Function in elderly cancer survivors depends on comorbidities. J Gerontol A Biol Sci Med Sci. 2003;M1119–24.
4.
go back to reference Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.PubMedCrossRef Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.PubMedCrossRef
5.
go back to reference Kornblith AB, Herndon II JE, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20years after adjuvant chemotherapy. Cancer. 2003;98:679–89.PubMedCrossRef Kornblith AB, Herndon II JE, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20years after adjuvant chemotherapy. Cancer. 2003;98:679–89.PubMedCrossRef
6.
go back to reference Ganz PA, Kwan L, Stanton AL, et al. Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol. 2011;29:1101–9.PubMedCrossRef Ganz PA, Kwan L, Stanton AL, et al. Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol. 2011;29:1101–9.PubMedCrossRef
7.
go back to reference Deimling GT, Arendt JA, Kypriotakis G, Bowman KF. Functioning of older, long-term cancer survivors: the role of cancer and comorbidities. J Am Geriatr Soc. 2009;57:S289–92.PubMedCrossRef Deimling GT, Arendt JA, Kypriotakis G, Bowman KF. Functioning of older, long-term cancer survivors: the role of cancer and comorbidities. J Am Geriatr Soc. 2009;57:S289–92.PubMedCrossRef
8.
go back to reference Cohen HJ. Functional assessment and the cancer survivor: something old, something new. J Natl Cancer Inst. 2010;102:1450–1.PubMedCrossRef Cohen HJ. Functional assessment and the cancer survivor: something old, something new. J Natl Cancer Inst. 2010;102:1450–1.PubMedCrossRef
9.
go back to reference Extermann M. Interaction between comorbidity and cancer. Cancer Control. 2007;14:13–22.PubMed Extermann M. Interaction between comorbidity and cancer. Cancer Control. 2007;14:13–22.PubMed
10.
go back to reference Keeler E, Guralnik JM, Tian H, Wallace RB, Reuben DB. The impact of functional status on life expectancy in older persons. J Gerontol A Biol Sci Med Sci. 2010;65:727–33.PubMedCrossRef Keeler E, Guralnik JM, Tian H, Wallace RB, Reuben DB. The impact of functional status on life expectancy in older persons. J Gerontol A Biol Sci Med Sci. 2010;65:727–33.PubMedCrossRef
11.
go back to reference Lunney JR, Lynn J, Foley DJ, et al. Patterns of functional decline at the end of life. JAMA. 2003;289:2387–92.PubMedCrossRef Lunney JR, Lynn J, Foley DJ, et al. Patterns of functional decline at the end of life. JAMA. 2003;289:2387–92.PubMedCrossRef
12.
go back to reference Sweeney C, Schmitz KH, Lazovich D, et al. Functional limitations in elderly female cancer survivors. J Nat Cancer Inst. 2006;98:521–9.PubMedCrossRef Sweeney C, Schmitz KH, Lazovich D, et al. Functional limitations in elderly female cancer survivors. J Nat Cancer Inst. 2006;98:521–9.PubMedCrossRef
13.
go back to reference Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004;96:376–87.PubMedCrossRef Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004;96:376–87.PubMedCrossRef
14.
go back to reference Silliman RA, Guadagnoli E, Rakowski W, et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol. 2002;20:2680–8.PubMedCrossRef Silliman RA, Guadagnoli E, Rakowski W, et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol. 2002;20:2680–8.PubMedCrossRef
15.
go back to reference Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef
16.
go back to reference Ware JE. SF-36 Health survey manual and interpretation guide. Boston: Nimrod; 1993. Ware JE. SF-36 Health survey manual and interpretation guide. Boston: Nimrod; 1993.
17.
go back to reference Biorner JB, Wallenstein GV, Martin MC, et al. Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin. 2007;23:731–9.CrossRef Biorner JB, Wallenstein GV, Martin MC, et al. Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin. 2007;23:731–9.CrossRef
18.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.
19.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.PubMedCrossRef
20.
go back to reference Schag CA, Ganz PA, Heinrich RL. Cancer Rehabilitation Evaluation System–short form (CARES-SF): a cancer specific rehabilitation and quality of life instrument. Cancer. 1991;68:1406–13.PubMedCrossRef Schag CA, Ganz PA, Heinrich RL. Cancer Rehabilitation Evaluation System–short form (CARES-SF): a cancer specific rehabilitation and quality of life instrument. Cancer. 1991;68:1406–13.PubMedCrossRef
21.
go back to reference Schafer JL, Olsen MK. Multiple imputation for multivariate missing-data problems: a data analysts’s perspective. Multivar Behav Res. 1998;33:545–71.CrossRef Schafer JL, Olsen MK. Multiple imputation for multivariate missing-data problems: a data analysts’s perspective. Multivar Behav Res. 1998;33:545–71.CrossRef
22.
go back to reference Rubin DB. Multiple imputation for non-response in surveys. New York: Wiley; 1987.CrossRef Rubin DB. Multiple imputation for non-response in surveys. New York: Wiley; 1987.CrossRef
24.
go back to reference Bernaards CA, Belin TR, Schafer JL. Robustness of a multivariate normal approximation for imputation of incomplete binary data. Stat Med. 2007;26:1368–82.PubMedCrossRef Bernaards CA, Belin TR, Schafer JL. Robustness of a multivariate normal approximation for imputation of incomplete binary data. Stat Med. 2007;26:1368–82.PubMedCrossRef
25.
go back to reference Schafer JL. Analysis of incomplete multivariate data. London: CRC; 1997. p. 147–92.CrossRef Schafer JL. Analysis of incomplete multivariate data. London: CRC; 1997. p. 147–92.CrossRef
26.
go back to reference Arndt V, Merx H, Sturmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer. 2004;40:673–80.PubMedCrossRef Arndt V, Merx H, Sturmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer. 2004;40:673–80.PubMedCrossRef
27.
go back to reference Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowska K, et al. Long-term prognostic role of functional limitation among women with breast cancer. J Natl Cancer Inst. 2010;102:1–10.CrossRef Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowska K, et al. Long-term prognostic role of functional limitation among women with breast cancer. J Natl Cancer Inst. 2010;102:1–10.CrossRef
28.
go back to reference Patterson RE, Squib N, Natarajan L, et al. Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Res Treat. 2011;127:541–7.PubMedCrossRef Patterson RE, Squib N, Natarajan L, et al. Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Res Treat. 2011;127:541–7.PubMedCrossRef
29.
go back to reference Klepin HD, Geiger AM, Tooze JA, et al. Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study. J Am Geriatr Soc. 2010;58:76–82.PubMedCrossRef Klepin HD, Geiger AM, Tooze JA, et al. Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study. J Am Geriatr Soc. 2010;58:76–82.PubMedCrossRef
30.
go back to reference Satariano WA, Ragheb NE, Buck KA, Swanson GM, Branch LG. Aging and breast cancer: a case–control comparison of instrumental functioning. J Aging Health. 1989;1:209–33.CrossRef Satariano WA, Ragheb NE, Buck KA, Swanson GM, Branch LG. Aging and breast cancer: a case–control comparison of instrumental functioning. J Aging Health. 1989;1:209–33.CrossRef
31.
go back to reference Wenzel BL, Fairclough DL, Brady MJ, Cella D, Garrett KM, Kluhsman BC, et al. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer. 1999;86:1768–74.PubMedCrossRef Wenzel BL, Fairclough DL, Brady MJ, Cella D, Garrett KM, Kluhsman BC, et al. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer. 1999;86:1768–74.PubMedCrossRef
32.
go back to reference Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639–46.PubMed Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639–46.PubMed
33.
go back to reference Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50:1947–54.PubMedCrossRef Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50:1947–54.PubMedCrossRef
34.
go back to reference Reuben DB, Cheh AI, Harris TB, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc. 2002;50:638–44.PubMedCrossRef Reuben DB, Cheh AI, Harris TB, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc. 2002;50:638–44.PubMedCrossRef
35.
go back to reference Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 2000;55:M709–15.PubMedCrossRef Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 2000;55:M709–15.PubMedCrossRef
36.
go back to reference Zhu S, Patel KV, Bandinelli S, Ferrucci L, Guralnik JM. Predictors of interleukin-6 elevation in older adults. J Am Geriatr Soc. 2009;57:1672–7.PubMedCrossRef Zhu S, Patel KV, Bandinelli S, Ferrucci L, Guralnik JM. Predictors of interleukin-6 elevation in older adults. J Am Geriatr Soc. 2009;57:1672–7.PubMedCrossRef
37.
go back to reference Brinkley TE, Leng X, Miller ME, et al. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci. 2009;64:455–61.PubMedCrossRef Brinkley TE, Leng X, Miller ME, et al. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci. 2009;64:455–61.PubMedCrossRef
38.
go back to reference Bower JE, Ganz PA, Tao ML, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009;15:5534–40.PubMedCrossRef Bower JE, Ganz PA, Tao ML, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009;15:5534–40.PubMedCrossRef
39.
go back to reference Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–51.PubMedCrossRef Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–51.PubMedCrossRef
40.
go back to reference LIFE Study Investigators, Pahor M, Blair SN, Espeland M, et al. Effects of a physical activity intervention on measures of physical performance: results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci. 2006;61:1157–65.PubMedCrossRef LIFE Study Investigators, Pahor M, Blair SN, Espeland M, et al. Effects of a physical activity intervention on measures of physical performance: results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci. 2006;61:1157–65.PubMedCrossRef
Metadata
Title
Decline in physical functioning in first 2 years after breast cancer diagnosis predicts 10-year survival in older women
Authors
Mary Sehl
Xiang Lu
Rebecca Silliman
Patricia A. Ganz
Publication date
01-03-2013
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0239-5

Other articles of this Issue 1/2013

Journal of Cancer Survivorship 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine